Heterobicyclic sphingosine 1-phosphate analogs
US10081646B2 · kind B2 · utility
0Cited by
9References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2017 |
| Grant date | Sep 25, 2018 |
| Priority date | — |
| Expiry date | Jun 13, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.